AP3A - Solution

P1-(5'-Adenosyl) P3-(5'-adenosyl) triphosphate, Sodium salt

Catálogo Nº Apresentação Preço (R$) Comprar
NU-506S 50 μl (10 mM)Sob demanda Adicionar ao Carrinho
NU-506L 5 x 50 μl (10 mM)Sob demanda Adicionar ao Carrinho
Structural formula of AP3A - Solution (P1-(5'-Adenosyl) P3-(5'-adenosyl) triphosphate, Sodium salt)
Structural formula of AP3A - Solution

For general laboratory use.

Envio: shipped on gel packs

Condições de armazenamento: store at -20 °C
Short term exposure (up to 1 week cumulative) to ambient temperature possible.

Validade: 12 months after date of delivery

Fórmula molecular: C20H27N10O16P3 (free acid)

Peso molecular: 756.41 g/mol (free acid)

CAS#: 5959-90-0

Pureza: ≥ 95 % (HPLC)

Forma: solution in water

Concentração: 10 mM - 11 mM

pH: 7.5 ±0.5

Propriedades espectroscópicas: λmax 259 nm, ε 27.0 L mmol-1 cm-1 (Tris-HCl pH 7.5)

Specific Ligands:

Ligand for P2X and P2Y receptors:
Agonist at P2Y1 receptor[1,2,3], at P2Y12 and P2Y13 receptors[4] and for P2X1 - P2X4 purinoreceptors[5]

Referências selecionadas:
[1] Szczepanska-Konkel et al. (2005) Effects of diadenosine polyphosphates on glomerular volume. Br. J. Pharmacol. 144 (8):1109.

[2] Yerxa et al. (2001) P1- (uridine 5')-P4- (2'-deoxycytidine 5')tetraphosphate tetrasodiumsalt a next generation P2Y2 receptor agonist for treatment of cystic fibrosis. J. Pharmacol. Exp. Ther. 302:871.

[3] Ralevic et al. (2001) Structure-activity relationships of diadenosine polyphosphates (ApnAs), adenosine polyphospho guanosines (ApnGs) and guanosine polyphospho guanosines (GpnGs) at P2 receptors in the rat mesenteric arterial bed. Br. J. Pharmacol. 134 (5):1073.

[4] Zhang et al. (2002) Identification and characterization of a novel Gαi-coupled ADP receptor from human and mouse. J. Pharmacol. Exp. Ther. 301 (2):705.

[5] Gualix et al. (2014) Presence of diadenosine polyphosphates in microdialysis samples from rat cerebellum in vivo: effect of mild hyperammonemia on their receptors. Purinergic Signal. 10 (2):349.

Guranowski et al. (2000) Selective degradation of 2'-adenylated diadenosine tri- and tetraphosphates, Ap (3)A and Ap (4)A, by two specific human dinucleoside polyphosphate hydrolases. Arch. Biochem. Biophys. 373:218.

Luo et al. (1999) Identification and characterization of diadenosine 5',5'-P1,P2 -diphosphate and diadenosine 5',5'-P1,P3-triphosphate in human myocardial tissue. FASEB J. 13:695.

Luthje et al. (1988) Catabolism of Ap4A and Ap3A in whole blood. The dinucleotides are long-lived signal molecules in the blood ending up as intracellular ATP in the erythrocytes. Eur. J. Biochem. 173:241.

Luthje et al. (1987) Catabolism of Ap4A and Ap3A in human serum. Identification of isoenzymes and their partial characterization. Eur. J. Biochem. 169:385.

Luthje et al. (1985) Catabolism of Ap3A and Ap4A in human plasma. Purification and characterization of a glycoprotein complex with 5'-nucleotide phosphodiesterase activity. Eur. J. Biochem. 149:119.

Bochner et al. (1984) AppppA and related adenylylated nucleotides are synthesized as a consequence of oxidation stress. Cell 37 (1):225.